Alternative Name: | PTH, Parathormone, Parathyrin |
|
Clone: | PTH/1717R |
|
Host: | Rabbit |
|
Isotype: | IgGκ |
|
Immunogen: | A synthetic peptide from the N-terminal region of human Parathyroid hormone. |
|
UniProt ID: | P01270 |
|
Species reactivity: | Human
|
|
Applications: | Flow Cytometry, IF, IHC (PS)
|
|
Recommended Dilutions/Conditions: | Flow Cytometry (0.5-1 µg/106 cells in 0.1 mL) Immunofluorescence (0.5-1 µg/mL) Immunohistochemistry (formalin-fixed paraffin sections) (0.5-1 µg/mL for 30 min at RT) Suggested dilutions/conditions may not be available for all applications. Optimal conditions must be determined individually for each application. |
|
Purity Detail: | Protein A affinity purified. |
|
Formulation: | Liquid. In 1X PBS containing 0.1 mg/ml BSA (US sourced) and 0.05% sodium azide. |
|
Shipping: | Blue Ice |
|
Long Term Storage: | +4°C |
|
Scientific Background: | PTH/Parathyroid hormone is a hormone produced by the parathyroid gland that regulates the concentration of calcium and phosphorus in extracellular fluid. This hormone elevates blood Ca2+ levels by dissolving the salts in bone and preventing their renal excretion. It is produced in the parathyroid gland as an 84 amino acid single chain polypeptide. It can also be secreted as N-terminal truncated fragments or C-terminal fragments after intracellular degradation, as in case of hypercalcemia. Defects in this gene are a cause of familial isolated hypoparathyroidism (FIH); also called autosomal dominant hypoparathyroidism or autosomal dominant hypocalcemia. FIH is characterized by hypocalcemia and hyperphosphatemia due to inadequate secretion of parathyroid hormone. Symptoms are seizures, tetany and cramps. FIH exist both as autosomal dominant and recessive forms of hypoparathyroidism. |
|
Regulatory Status: | RUO - Research Use Only |
|